We use GFP as a fate map marker in chimeric mice. We are working on a protocol for a skin digest to analyze the turnover of leukocytes in the skin. The protocol works beautifully on a non-GFP animal, but when GFP is involved, only about 70- 80% of the CD45+ population is GFP+ And the fluorescence is extremely high making compensation extremely difficult. Does anyone have experience in using GFP in the skin of mice. Is this varying expression expected? 

Similar questions and discussions